Radiation associated hypothyroidism (Scientific review)

"Radiation and Risk" 1997. Vol. 10, pp.62-84

Authors

Tsyb A.F., Matveenko E.G., Nestaiko G.B., Gorobets V.F.
Medical Radiological Research Center RAMS, Obninsk

Abstract

The authors analyse current concepts of mechanisms of development, diagnostic methods and indicators of radiogenic risk of hypothyroidism due to exposure of thyroid tissue to external and internal radiation.

Key wordsа
The mechanism of development, diagnostic methods, indicators of the radiogenic risk of hypothyroid states, the effects of external and internal ionizing radiation, thyroid tissue.

References

1. Avramenko N.L. The function of the thyroid gland and specific autoimmune reactions in children Narodichsky district of Zhytomyr region 2.5 years after the accident at the Chernobyl nuclear power plant: Auto-ref. dis ... cand. med. sciences. Obninsk, 1992.

2. Atabek A.A. Radioactive iodine in the treatment of thyrotoxicosis. M .: Medgiz Publ., 1959. P. 183.

3. Biological effects of inhalation radionuclides. Trans. from English. M .: Energoatomizdat Publ., 1984.

4. Vasilenko I.Ya. Radiation hygienic value of iodine isotopes. Journal hygiene epidemiol. microbiol. immunol. (Prague). 1980. No. 2. PP. 131.

5. Vasilenko I.Ya. Radiation hazard of iodine radioisotopes. Atomic Energy. 1987. No. 4. P. 244.

6. Vasilenko I.Ya. The carcinogenic effect of radioactive isotopes of iodine. Question of oncol. 1988. No. 6.

C. 648.

7. Voronetsky I.B., Zubovsky G.A. Changes in the thyroid gland under the influence of radiation. Med. radiol. 1990. No. 5. P. 33.

8. Vorontsova T.V., Galitskaya N.N., Attorney A.M. and others. A new set of laboratory tests to identify risk groups with autoimmune thyroiditis. Scientific and practical aspects of preserving the health of people exposed to radiation as a result of the accident at the Chernobyl nuclear power plant. Proc. rep. conf. Minsk, 1991. P. 155.

9. Grigoriev Yu.G., Popov V.I., Shafirkin A.V. Somatic effects of chronic gamma irradiation. M .: Energoatomizdat Publ., 1986.

10. Davydova E.G., Kobaev V.F., Markova S.V. Features of the clinical and functional state of the thyroid gland in children and adolescents of the BSSR exposed to radionuclides as a result of the Chernobyl accident, according to population-based studies. Scientific and practical aspects of maintaining the health of people exposed to radiation as a result of the accident at the Chernobyl nuclear power plant: Proc. rep. conf. Minsk, 1991. P. 137.

11. Dose dependencies of non-stochastic effects, basic concepts and values ​​used in the ICRP. Publications No. 41, 42. ICRP. Trans. from English. M .: Energoatomizdat Publ., 1987. 135 p.

12. Egorov P.I., Tsfasman A.Z. Radioactive iodine in the diagnosis and treatment of diseases of the thyroid gland. M .: Medgiz Publ., 1962.

13. Ermakova O.V., Tkachev A.V. Some aspects of thyroid radiosensitivity. Proc. of Komi scientific Center of the Ural Academy of Sciences of the USSR. 1988. No. 97. P. 74.

14. Zhorno L.Ya., Ilyin B.I., Mikhaydarova P.P. Morphofunctional changes of the thyroid gland with isolated and combined effects of radioiodine. Radiobiology. 1982. Vol. 22. P. 553.

15. Zedgenidze G.A., Tsyb A.F. Clinical lymphography. M .: Medicine Publ., 1978.

16. Zufarov K.A., Shishova E.K., Tashkhedzhaev P.I. Reaction of the thyroid gland to the action of penetrating radiation. Radiation endocrinology. Obninsk, 1967. P. 35.

17. Ilyin L.A., Arkhangelskaya G.V. Possible effects of exposure to radioactive iodine on humans. Med. radiology. 1973. No. 8. P. 66.

18. Ilyin L.A., Arkhangelskaya G.V., Konstantinov Yu.O. et al. Radioactive iodine in the problem of radiation safety. M .: Atomizdat Publ., 1972. 272 p.

19. Ilyin B.N., Borisova V.V., Fedorova A.V. Remote effects with the combined action of certain radionuclides. Biological effects of low doses of radiation. M., 1983. P. 103.

20. Ilyin L.A., Balonov M.I., Buldagov L.A. et al. Ecological features and biomedical consequences of the accident at the Chernobyl nuclear power plant. Honey. radiology. 1989. No. 11. P. 59.

21. Ionizing radiation. Sources and Biological Effects: 1982 Report of the General Assembly. UNSCEAR. New York: UN, 1982. Vol. 2. 780 p.

22. Sources and Effects of Ionizing Radiation: Report of the General Assembly for 1977. UNSCEAR. New York: UN, 1978. Vol. 1. 382 p.

23. Kalistratova V.S., Tishchenko G.S. The role of hormonal background in the manifestation of remote effects caused by radioactive iodine. Biological effects of low doses of radiation. M., 1983. P. 65.

24. Klassovsky Yu.A. On the role of the microdistribution factor dose on the effect of irradiation of the thyroid gland. Bulletin of the Academy of Medical Sciences of the USSR. 1967. No. 12. P. 25.

25. Konoplyannikov A.G. Radiobiology of stem cells. M .: Energoatomizdat Publ., 1984.

26. Kuzin A.M. Structural-metabolic theory in radiobiology. M .: Nauka Publ., 1986. 284 p.

27. Levin V.A. Determination of radiation load on the thyroid gland and the body in the diagnostic use of 131I. Med. radiology. 1970. No. 6. P. 62.

28. Likhtarev I.A., Shandala N.K., Gulko G.M. et al. Epidemiological monitoring after the Chernobyl accident: theoretical and practical aspects. Scientific and practical aspects of maintaining the health of people exposed to radiation as a result of the accident at the Chernobyl nuclear power plant: Proc. rep. conf. Minsk, 1991. P. 134.

29. Lyutsko A.M. Background Chernobyl. Minsk, 1990.

30. Matveenko E.G. Investigation of iodine metabolism in health and disease by the method of dynamic radiometry of the whole body and individual organs: Author's abstract. dis ... dr. med sciences. M., 1972.

31. Moskalev Yu.I. Radiobiology of incorporated radionuclides. M .: Energoatomizdat Publ., 1989. 263 p.

32. Moskalev Yu.I. Long-term effects of ionizing radiation. M .: Medicine Publ., 1991.

33. The condition of the thyroid gland and hormonal homeostasis in children exposed to radiation as a result of the Chernobyl accident in Belarus. Scientific and practical aspects of maintaining the health of people exposed to radiation as a result of the accident at the Chernobyl nuclear power plant: Proc. rep. conf. Minsk, 1991. C. 148.

34. Tkachev A.V. Aspects of radiation damage to the thyroid gland: Author's abstract. dis ... dr. med. sciences. M., 1970.

35. Tronko N.D., Markov V.V., Kashkadamov A.V. et al. Iodine, 131I, and some questions on thyroidology. Prob. endocrinology. 1989. No. 6. P. 87.

36. Filippova L.G., Nifatov A.P., Buldagov L.A. Long-term effects of the combined effect of external gamma radiation and incorporated radionuclides. Biological effects of low doses of radiation. M., 1983. P. 107.

37. Tsyb A.F., Ivanov V.K., Airapetov S.A. et al. Radiation-epidemiological analysis of data from the State Register of persons exposed to radiation as a result of the accident at the Chernobyl NPP. Vestn. USSR Academy of Medical Sciences. 1991. No. 11. P. 32.

38. Tsyb A.F., Matveenko E.G., Gorobets V.F. The functional state of the pituitary-thyroid system in children and adolescents exposed to radiation as a result of the accident at the Chernobyl nuclear power plant. Honey. radiol. 1991. No. 7. P. 4.

39. Chochina K.N., Svasberg E.M. The study of thyroid function using radioactive iodine in the treatment of laryngeal cancer. Honey. radiol. 1960. No. 8. P. 14.

40. Abdel-Nabi H., Ortman J.R. Radiobiological effects of 131I and 125I on the DNA of rat thyroid. 1. Comparative study with emphasis on the postradiation hypothyroidism occurence. Rad. Res. 1983. Vol. 93. P. 525.

41. Adams W.H., Engle J.R., Harper J.A. et al. Medical status of Marshallese accidentally exposed to 1954 Bravo fallout radiation: January 1983 through December 1984. BNL 51958. Upton, NY: Brookhaven National Laboratory, 1984.

42. Adams W., Harper J., Heotis P., Scott W. Medical status of Marshallese accidentally exposed to 1954 Bravo fallout radiation: January 1980 through December 1982. Technical Report BNL 51761. Upton, NY: Brookhaven National Lab., 1984, p. 51.

43. Adams W.H., Harper J.A., Rittmaster R.S. et al. Medical status of Marshallese accidentally exposed to 1954 Bravo fallout radiation: January 1980 through December 1982. BNL 51761. Upton, NY: Brookhaven National Lab., 1982.

44. Alevizaki C.C., Alevizaki-Harhalaki M.C., Ikkos D.C. Radioiodine-131 treatment of thyrotoxicosis: dose required for and some factors affection the early induction of hypothyroidism. Eur. J. Nucl. Med. 1985. Vol. 10. P. 450.

45. Anno Y., Sasaki T., Takeshita A. et al. Incidence of hypothyroidism after radioiodine treatment of hyperthyroidism. Nippon Igaku Hoshasen Gakkai Zasshi, 1975. V. 35. P. 545.

46. Anno Y., Takeshita A., Iwamoto M. Medical use of radioisotopes in Japan, especially for treating hyperthyroidism and evaluation of the consequent radiation risk. Gann Monograph No. 9, Radiology of cancer, Tokyo, Maruzen, 1970, p. 241.

47. Aubin P.M., Kinsley R.M., Andrews G.A. External irradiation of the thyroid gland in dogs. Am. J. Roent. Rad. Ther. Nucl. Med. 1957. Vol. 78. P. 864.

48. Bantle J.P., Lee C.K.K., Levitt S.H. Thyroxine administration during radiation therapy to the neck does not prevent subsequent thyroid dysfunction. Int. J. Radiat. Oncol. Biol. Phys. 1985. V. 11. P. 1999.

49. Becker D.V. Choice of therapy for Graves' hyperthyroidism. New Engl. J. Med. 1984. Vol. 311. P. 464.

50. Becker D.V. Medical radiation: comparison of iodine-131 therapy and alternative treatment of hyperthyroidism. Radiation and the thyroid.Ed. Sh.Nagataki. Amsterdam-Tokyo: Excerpta medica, 1989. P. 57.

51. Becker D.V. Radioactive iodine (131I) in the treatment of hyperthyroidism. Thyroid disease. New York-London-Paris, 1982. P. 145.

52. Becker D.V., Hurley J.R. Current status of radioiodine (131I) treatment of hyperthyroidism. Nuclear medicine annual. New York: Raven Press, 1982. P. 10.

53. Becker D.V., McConahey W.M., Dobyns B.M. et al. The results of radioiodine treatment of hyperthyroidism. A preliminary report of the thyrotoxicosis follow-up study. Further advances in thyroid research. Eds. K.Fellinger, R.Hofer. Vienna: Wiener Medizinische Akademie, 1971. Vol. 1. P. 603.

54. Benson A.B. Hanford radioactive fallout. Hanford radioactive iodine-131 release (1944-1956). Are there observable health effects? Cheney: Hight Impact Press, 1989. P. 119.

55. Bertok L., Nagy S.U. Effect of radiation on serum T4 level and response of thyroid gland to exogenous TSH in rats. J. Radiat. Res. 1986. Vol. 27. P. 225.

56. Blagg C.R. Antibodies to thyroglobulin in patients with thyrotoxicosis treated with radioactive iodine. Lancet. 1960. Vol. 2, No. 7165. P. 1364.

57. Braverman L.E. Iodine induced thyroid disease. Acta Med. Austriaca. 1990. Vol. 17, suppl. 1. P. 29.

58. Brill A.B., Becker D.V. Safety of 131I treatment of hyperthyroidism. The thyroid gland: practical, clinical treatise/Ed. L. van Middlesworth. Chicago: Yearbook Medical Publishers, 1986. P. 347.

59. Brinckmeyer L.M., Worm A.M., Nissen N.I. Thyroid function in malignant lymphoma. Acta Med. Scand. 1977. Vol. 202. P. 475.

60. Carmel R.J., Kaplan H.S. Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications. Cancer. 1976. Vol. 37. P. 2813.

61. Conard R.A. A twenty-year review of medical findings in a Marshallese population accidentally exposed to radioactive fallout: technical report. BNL No.50424. Brookhaven, 1975. P. 154.

62. Conard R.A. Late radiation effects in Marshall Islands exposed to fallout 28 years ago. Radiation carcinogenesis: epidemiology and biological significance. Eds. J.D.Boice, J.F. Fraumeni. New York: Raven Press, 1984. P. 57.

63. Conard R.A. Medical survey of the people of Rongelap and Utirik Islands eleven and twelve years after exposure to fallout radiation (March 1965 and March 1966).

- New York: Brookhaven National Lab., Associated Universities, Inc., BNL 50029 (T-446), 1967.

64. Conard R.A. Summary of thyroid findings in Marshallese 22 years after exposure to radioactive fallout. Radiation-associated thyroid carcinoma. Eds. L.De Groot, L. Frohman, E.Kaplan, S.Refetoff. New York: Grune and Stratton, 1977. P. 241.

65. Conard R.A., Knudsen K.D., Dobyns B.M. et al. A twenty year review of medical findings in a Marshallese population accidentally exposed to radioactive fallout. BNL 50424. Upton, NY: Brookhaven National Lab., 1974.

66. Conard R.A., MacDonald H.E., Lowrey A. et al. Medical survey of Rongelap people five and six years after exposure to fallout. BNL 609 (T179). Upton, NY: Brookhaven National Lab., 1960.

67. Conard R.A., Paglia D., Larsen P. et al. Review of medical findings in a Marshallese population twenty-six years after accidental exposure to radioactive fallout. Upton, NY: Brookhaven National Lab., 1980. P. 138.

68. Coischke H.K. Die chronisch-lymphozytare autoimmune Thyreoiditis: eine haeufige Schilddruesenerkrankung. Medizinische Klinik, 1980. Bd. 7. H. 2. S. 46.

69. Constine L.S. et al. Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer. 1984. Vol. 53. P. 878.

70. Cooper D.S. L-thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo controlled trial. Ann. Intern. Med. 1984. Vol. 101. P. 18.

71. Cunnien A.J., Hay I.D., Gorman C.A. et al. Factors influencing the increasing incidence of radio iodine induced hypothyroidism in Graves' disease. J. Nucl. Med. 1981. Vol. 22. P. 6.

72. De Groot L.J. Radiation and thyroid disease. Baillieres Clin. Endocrinol. Metab. International Practice and Research. 1988. Vol. 2. P. 777.

73. De Groot L., Paloyan E. Thyroid carcinoma and radiation: a Chicago endemic. JAMA. 1973. Vol. 225. P. 487.

74. De Groot L.J., Frohman L.A., Kaplan E.L. Radiation associated thyroid carcinoma. New-York: Grune a. Stratton, 1977. P. 1.

75. De Groot L.J., Pinnameneni K., Refetoff S. Retrospective and prospective study of radiation-induced thyroid disease. Am. J. Med. 1983. Vol. 74. P. 852.

76. Delange F. Iodine nutrition and risk of thyroid irradiation from nuclear accidents. Iodine prophylaxis following nuclear accidents. Oxford, New-York, Frankfurt, Sao Paulo, Sidney, Tokyo, Toronto, 1988. P. 45.

77. Devney R.B. Serial thyroid function measurements in children with Hodgkin's disease. J. Pediatr. 1984. Vol. 105. P. 223.

78. Dimitrovska A., Georgievska B., Jovanovski D., Velkov K. Thyroid function after irradiation and surgery for laryngeal cancer. Radiol. Jugosl. 1982. Vol. 16. P. 331.

79. Dimitrovska A., Karanfinski B., Georgieva B. et al. Thyroid status following irradiation for laryngeal cancer. Adv. Radiol. Oncol. 1992. Vol. 26. P. 208.

80. Dobyns B.M., Didtschenko J. Nuclear changes in thyroidal epithelium following radiation from radioiodine. J. Clin. Endocrinol. Metabol. 1961. Vol. 21. P. 699.

81. Dobyns B.M., Sheline G.E., Workman J.B. et al. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism. A report of the cooperative thyrotoxicosis follow-up study. J. Clin. Endocrinol. Metab. 1974. Vol. 38. P. 976.

82. Donaldson S.S., Glatstein E., Rosenberg S.A. et al. Pediatric Hodgkin's disease. II. Results of therapy. Cancer. 1976. Vol. 37. P. 2436.

83. Doniach I. Experimental evidence of etiology of thyroid cancer. Proc. R. Soc. Med. 1974. Vol. 67. PP. 1103- 1115.

84. Einhorn J., Wicklund H. Hypothyroidism following 131I treatment for hyperthyroidism. J. Clin. Endocrinol. Metabol. 1966. Vol. 26, No. 1. P. 33.

85. Einhorn J., Wikholm G. Hypothyroidism after external irradiation to the thyroid region. Radiology. 1967. Vol. 88. P. 326.

86. Einhorn J., Fagraeus A., Jonson J. Thyroid antibodies in euthyroid subjects after iodine-131 therapy . Radiat. Res. 1966. V. 28. P. 296.

87. Farley P.C. Thyroid dysfunction following radiation therapy for lymphoma in the military population. Milit. Med. 1983. Vol. 148. P. 740.

88. Felix H., Dupre N., Dupre M. et al. Incidence a long terme d'une radiotherapie pour cancer du larynx, sur l'apprition d'un myxoedeme. Lyon Med. 1961. Vol. 206. P. 1043.

89. Feyerabend T., Kapp B., Richter E. Incidence of hypothyroidism after irradiation of the neck with special reference to lymphoma patients: a retrospective and prospective analysis. Acta Oncol. 1990. Vol. 29. P. 597.

90. Fleming I.D. et al. Thyroid dysfunction and neoplasia in children receiving neck irradiation for cancer. Cancer. 1985. Vol. 55. P. 1190.

91. Fueger C.F. Biologische Effekte und Risiken akzidenteller Radionuklidinkorporation. Acta med. austriaca. 1986. Bd. 13. S. 86.

92. Fuks T., Glatstein E., Marsa G.W. et al. Long term effects of external radiation on the pituitary and thyroid glands. Cancer. 1976. Vol. 37. P. 1152.

93. Gimlette T.M., Critchley M., Squire C.R. Factors predicting hypothyroidism in long-term follow-up after 131I therapy. Nuklearmedizin. 1988. Vol. 27. P. 135.

94. Glatstein E., McHardy-Young S., Eltringhalm J.R. et al. Alterations in serum thyrotropin (TSH) and thyroid function following radiotherapy in patients with malig- nant lymphoma. J. Clin. Endocrinol. Metab. 1971. Vol. 32. P. 833.

95. Goslings B.M. Chernobyl fallout and the thyroid gland: a review of radioiodine exposure in Europe and its potential carcinogenic effect on the thyroid. Radiation and the thyroid/Eds. Sh.Nagataki. Amsterdam-Tokyo: Excerpta Medica. 1989. P. 25.

96. Graham G.D., Burman K.D. Radioiodine treatment of Geaves' disease. An assessment of its potential risks. Ann. Intern. Med. 1986. Vol. 105. P. 900.

97. Green D.M. Thyroid function in pediatric patients after neck irradiation for Hodgkin's disease. Med. Ped. Oncol. 1980. Vol. 8. P. 127.

98. Greig W.R., Boyle J.A., Buchanam W.W., Fulton S. Clinical and radiobiological observations on latent effects of X-irradiation on the thyroid gland. J. Clin. Endocrinol. 1965. Vol. 25. P. 1009.

99. Halnan K.E. Risks from radioiodine treatment of thyrotoxicosis. Br. Med. J. 1983. Vol. 287. P. 1821.

100. Hamada N., Itoh K., Mimura T. et al. Long-term results of 131I treatment of hyperthyroidism factors influencing the incidence of hypothyroidism. Kaku Igaku. 1979. Vol. 16. P. 1343.

101. Hancock S.L., Cox R.S., Dougall I.R. Thyroid disease after treatment of Hodgkin's disease. N. Eng. J. Med. 1991. Vol. 325. P. 599.

102. Hara M., Kitabatake T. Late side effect of 131I treatment for hyperthyroidism. Rinsho Hoshasen. 1973. Vol. 18. P. 527.

103. Hedley A.J., Bewsher P.D., Jones S.J. et al. Late onset hypothyroidism after subtotal thyroidectomy for hyperthyroidism: implications for long term follow-up. Br. J. Surg. 1983. Vol. 70. P. 740.

104. Hennemann G., Krenning E.P., Sankarana-rayanan K. Place of radioactive iodine in treatment of thyrotoxicosis. Lancet. 1986. Vol. 1. P. 1369.

105. Hoffman D.A. Late effects of 131I therapy in the United States. Radiation carcinogenesis: epidemiology and biological significance. Eds. Boice J.D., Fraumeni J.F. New York: Raven Press, 1984. P. 273.

106. Hollingsworth D.R., Hamilton H.B., Tamagaki Thyroid disease: a study in Hiroshima. Japan Medicine, 1963. Vol. 42. P. 47.

107. Holm L.E. Changing annual incidence of hypothyroidism after iodine-131 therapy for hyperthyroidism, 1951-1975. J. Nucl. Med. 1982. Vol. 23. P. 108.

108. Holm L.E. Malignant disease following iodine-131 therapy in Sweden. Radiation carcinogenesis: epidemiology and biological significance. Eds. Boice J.D., Fraumeni J.F. New York: Raven Press, 1984. P. 263.

109. Holm L.E., Eklund G., Lundell G. Incidence of malignant thyroid tumors in humans after exposure to diagnostic doses of iodine-131. II. Estimation of actual thyroid gland size, thyroidal radiation dose and predicted versus observed number of malignant thyroid tumors. JNCI. 1981. Vol. 65. P. 1221.

110. Holm L.E., Lundell G., Walider G. Incidence of malignant thyroid tumors in humans after exposure to diagnostic doses of iodine-131. I. Retrospective cohort study. JNCI. 1980. Vol. 64. P. 1055.

111. Holt G. Serum thyroglobulin after mantle irradiation for Hodgkin's disease. Clin. Endocrinol. 1983. Vol. 18. P. 605.

112. Hopoewell J.W., Camping D., Calro W. Vascular irradiation damage: its cellular basis and likely consequences. Br. J. Cancer. 1986. Vol. 53, suppl. 7. P. 181.

113. Ito Ch., Kato M., Mito K. et al. Study on the effect of atomic bomb radiation on thyroid function. Hiroshima J. Med. Sci. 1987. Vol. 36. P. 13.

114. Johnson R.E., Ruhl U., Johnson S. et al. Split course radiotherapy of Hodgkin's disease. Cancer. 1976. Vol. 37. P. 1713.

115. Jost D.T., Gaggeler H.W., Baltensperger U. Chernobyl fallout in size-fractioned aerosol. Nature. 1986. Vol. 324. P. 22.

116. Kaise K., Saito S., Sakurada T. et al. Thyroid nodules after radioiodine (131I) therapy for Graves' disease. Kaku Igaku. 1984. Vol. 21. P. 215.

117. Kaplan M.M. Risk factors for thyroid abnormalities after neck irradiation for childhood cancer. Am. J. Med. 1983. Vol. 74. P. 272.

118. Kaplan M.M., Boice J.D., Ames D.B., Rosenstein M. Thyroid, parathyroid and salivatory gland evaluation in patients exposed to multiple fluoroscopic examinations during tuberculosis therapy: a pilot study. J. Clin. Endocrinol. Metab. 1988. Vol. 66. P. 376.

119. Kim Y.H., Fagos J.V., Sisson J.C. Thyroid function following neck irradiation for malignant lymphoma. Radiology. 1980. Vol. 134. P. 205.

120. Komorowski R.A., Hanson G.A. Morphologic changes in the thyroid following low-dose childhood radiation. Arch. Pathol. Lab. Med. 1977. Vol. 101. P. 36.

121. Konishi J., Kasagi K., Iida Y. et al. Optimization and clinical assessment of a radioreceptor assay for thyrotropin-binding inhibitor immunoglobulins. Endocrinol. Jpn. 1987. Vol. 34. P. 13.

122. Konishi J., Iida Y., Kasagi K. et al. Radiation therapy for Graves' disease in Japan. Radiation and thyroid. Ed. Nagataki S. Amsterdam, Princeton, Hong-Kong, Tokyo, Sydney: Excepta Medica, 1989. P. 68.

123. Koulumies M., Voutilainen A., Koulumies R. Effect of X-ray irradiation of laryngeal cancer on the function of the thyroid gland. Ann. Int. Med. Fenn. 1964. Vol. 53. P. 89.

124. Kubo A., Kondo M., Kinoshita F. et al. Hypothyroidism following 131I therapy for hyperthyroidism. Kaku Igaku. 1977. Vol. 14. P. 59.

125. Larsen P.R., Conard R.A. Thyroid hypofunction appearing as a delayed manifestation of accidental exposure to radioactive fallout in Marshallese population: Technical report BNL No. 24104. Brookhaven, 1978. 148 p.

126. Larsen P.R., Conard R.A., Knudsen K.D. et al. Thyroid hypofunction after exposure to fallout from a hydrogen bomb explosion. JAMA. 1982. Vol. 247. P. 1571.

127. Lavelle R.J. Thyroid function after radiotherapy and total laryngectomy in the treatment of carcinoma of the larynx. Ann. Otol. Rhinol. Laryngol. 1971. Vol. 80. P. 593.

128. Law M.F. Radiation-induced vascular injury and its relation to late effects in normal tissues. Advanc. Rad. Biol. 1981. Vol. 9. P. 37.

129. Lessard E.T., Brill A.B., Adams W.H. Thyroid cancer in the Marshallese: relative risk of short-lived internal emitters and external radiation expposure. 4th Intern. Radiopharmaceutical Dosimetry Symposium. Geneva, 1986. P. 628.

130. Lessard E.T., Greenhouse N.A., Miltenberger R.P. A reconstruction of chronic dose equivalents for Rongelap and Utirik residents 1954 to 1980. BNL 51257. Upton, NY: Brookhaven National Laboratory, 1980.

131. Lessard E.T., Miltenberger R.P., Cohn S.H. et al. Protracted exposure to fallout: the Rongelap and Utirik experience. Health Physics. 1984. Vol. 46. P. 511.

132. Lessard E., Miltenberger R., Conard R. et al. Thyroid absorbed dose for people at Rongelap, Utirik and Sifo on March 1, 1954, BNL 51882. Upton, NY: Brookhaven National Laboratory, 1985.

133. Lindsay S., Chaikoff I.L. The effects of irradiation on the thyroid gland with particular reference to the induction of thyroid neoplasms: a review. Cancer Res. 1964. Vol. 24. P. 1099.

134. Lindsay S., Dailey M.E., Jones M.D. Histologic effects of various types of ionizing radiation on normal and hyperplastic human thyroid gland. J. Clin. Endocrinol. 1954. Vol. 14. P. 1179.

135. Logan J. Thyroid hypofunction in patients with lymphomatous tumours. N. Z. Med. J. 1965. Vol. 64. P. 135.

136. Loutit J.F., Marley W.G., Russel R.S. THR nuclear reactor accident at Windscale, October 1957: environmental aspects. The hazards to man of nuclear and allied radiation: report No. Cmnd 1225. London, 1960. P. 129.

137. Marcial-Vega V.A., Order S.E., Lastner G. Prevention of hypothyroidism related to mantle irradiation for Hodgkin's disease: preparative phantom study. Int. J. Radiat. Oncol. Biol. Phys. 1990. Vol. 18. P. 613.

138. Markson J.L., Flatman G.E. Myxoedema after deep X-ray therapy to the neck. Br. Med. J. 1965. Vol. 1. P. 1228.

139. Matsuoka M., Hara M., Utosawa M. Long-term results and side effects of 131I treatment for hyperthyroidism. Rinsho Hoshasen. 1967. Vol. 12. P. 528.

140. Mauch P.M. An evaluation of long-term survival and treatment complications in children with Hodgkin's disease. Cancer. 1983. Vol. 51. P. 925.

141. Maxon H.R., Saenger E.L., Thomas S.R. et al. Clinically important radiation associated thyroid disease. JAMA. 1980. Vol. 224. P. 1802.

142. Maxon H.R., Thomas S.R., Saenger E.L. Ionizing irradiation and the induction of cliically significant disease in the human thyroid gland. Am. J. Med. 1977. Vol. 63. P. 967.

143. Mettler F.A., Moseley R.D. Medical effects of ionizing radiation. Orlando, Florida: Grune and Stratton, 1985.

144. Michaelson M., Quinlau W.J., Casarett G.W. et al. Radiation-induced thyroid dysfunction in the dog. Radiat. Res. 1967. Vol. 30. P. 38.

145. Miyake T., Torizuka K. Results of 131I treatment of hyperthyroidism in Japan. Nippon Naibunpi Gakkai Zasshi. 1963. Vol. 39. P. 805.

146. Miyake T., Torizuka K. Statistical analysis of the results of 131I treatment for hyperthyroidism. Kaku Igaku. 1966. Vol. 3. P. 79.

147. Morgan G.W., Freeman A.P., McLean R.G. et al. Late cardiac, thyroid and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease. Int. J. Radiat. Oncol. Bio. Phys. 1985. Vol. 11. P. 1925.

148. Morimoto I., Yoshimoto Y., Sato K. et al. Serum TSH, thyroglobulin and thyroidal disorders in atomic bomb survivors exposed in youth: 30-year follow-up study. J. Nucl. Med. 1987. Vol. 28. P. 1115.

149. Moser E., Roedler H.D. Jod-131: Biokinetik, Strahlenexposition sowie Risikoabschaetzung im Zusammenhang mit dem Reaktorunfall in Thernobyl. Fortschr. Gel. Roentgen. Str. Nuklearmed. 1987. Bd. 146. S. 711.

150. Murken R.E., Duvall A.J. Hypothyroidism following combined therapy in carcinoma of the laryngopharynx. Laryngoscope. 1972. Vol. 82. P. 1306.

151. Nagataki S. Delayed effects of atomic bomb radiation on the thyroid. Radiation and the Thyroid. Amsterdam, Princeton, Hong Kong, Tokyo, Sydney, 1989. P. 1.

152. Nagataki S., Hirayu H. Incidence of thyroid disease in Japan, where iodine intake is several milligrams per day. International Workshop Iodine and Thyroid Autoimmunity. Holzhausen, Ringgau, 1988. P. 137.

153. Nagataki S., Hirayu H., Izumi M. et al. High prevalence of thyroid nodule in area of radioactive fallout. Lancet. 1989. Vol. 2. P. 375.

154. Nair N., Advani S.H., Dinshaw K.A. Thyroid disfunction following mantle radiotherapy for Hodgkin's disease. Int. J. Nucl. Med. Biol. 1984. Vol. 11. P. 175.

155. Nelson D.F., Reddy K.V., O'Mara R.E. et al. Thyroid abnormalities following neck irradiation for Hodgkin's disease. Cancer. 1978. Vol. 42. P. 2553.

156. NRCP. Recommendations of the National Reseach Council on Radiation Protection and Measurements, induction of thyroid cancer by ionizing radiation. NRCP Report No. 80. Bethesda, Maryland: NRCP, 1985.

157. O'Gorman P., Staffurth J.S., Ballentyne M.R. Antibody response to thyroid irradiation. J. Clin. Endocrinol. Metabol. 1964. Vol. 24. P. 1072.

158. Okajima S. Dose estimation from residual and fallout radioactivity, fallout in the Nagasaki-Nishiyama district. J. Radiat. Res. 1975. Vol. 16, Suppl. P. 35.

159. Okajima S., Takeshita K., Antoku S. et al. Radioactive fallout effects of the Nagasaki atomic bomb. Health Phys. 1978. Vol. 34. P. 621.

160. Parker L.N., Belsky J.L., Mandai T. et al. Serum thyrotropin level and goiter in relation to childhood exposure to atomic radiation. J. Clin. Endocrinol. Metab. 1973. Vol. 37. P. 797.

161. Pinchera A., Fenzi G.F., Mariotti S. et al. Iodine and autoimmune thyroid disease. Iodine prophylaxis following nuclear accidents. Oxford, New York, Frankfurt, Sao Paulo, Sidney, Tokyo, Toronto, 1988. P. 39.

162. Poussin-Rosillo H., Nisce L.Z., Lee B.J. Complications of total nodal irradiation of Hodgkin's disease, stages III and IV. Cancer. 1978. Vol. 42. P. 437.

163. Prager D., Sembrot J.T., Southard M. Cobalt-60 therapy of Hodgkin's disease and the subsequent development of hypothyroidism. Cancer. 1972. Vol. 29. P. 458.

164. Protection of the thyroid gland in the event of releases of radioiodine: Report No.55/NCRP. Washington, 1977. 60 p.

165. Radford E., Talbott E., Schmetz R. et al. Effect of elevated gamma-ray exposures on the prevalence of thyroid abnormalities in a community. Radiation research: somatic and genetic effects. Proc. of the 7th Intern. Congr. of Radiation Research Eds. J.Broerse, G. Barendsen, H.Kal, A. van der Kogel. C 8-12, Martimes-Nijhoff, the Hague, 1983 (Abstr.).

166. Rall J.E., Conard R.A. Elevation of serum protein-bound iodine level in inhabitants of the Marshall Islands. Am. J. Med. 1966. Vol. 40. P. 883.

167. Rallison M.L., Dobyns B.M., Keating F.R. et al. Thyroid disease in children. A survey of subjects potentially exposed to fallout radiation. Am. J. Med. 1974. Vol. 56. P. 457.

168. Ridgeway E.C. Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 1981. Vol. 53. P. 1238.

169. Robbins J., Adams W.H. Radiation effects in the Marshall Islands. Radiation and thyroid/Rd. Sh. Nagataki. Amsterdam, Tokyo: Excerpta Medica, 1989. P. 11.

170. Rogoway W.M., Finkelstein S., Rosenberg S.A. et al. Myxedema developing after lymphangiography and neck irradiation. Clin. Res. 1966. Vol. 14. P. 133 (abstract).

171. Rom E., Moden B. Benign and malignant thyroid neoplasms after childhood irradiation for tinea capitis. J. Nat. Cancer Inst. 1980. Vol. 65. P. 7.

172. Rubin S., Casarett G.W. The endocrine glands. Clinical radiation pathology. Ed. W.B. Saunders. Philadelphia, 1968. Vol. 2. P. 721.

173. Safa A.M., Schumacher O.P., Rodriquez-Antunez A. Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism. J. Engl. J. Med. 1975. Vol. 292. P. 167.

174. Saito S., Sakurada T., Yamamoto M. et al. Long-term results of radioiodine (131I) treatment in 331 patients with Graves' disease. Nippon Naika Gakkai Zasshi. 1979. Vol. 68. P. 724.

175. Salo A. Information exchange after Chernobyl. IAEA Bulletin. 1986. Vol. 28. P. 18.

176. Salo A. Radionuclide levels in Europe after Chernobyl. Paper presented at the European Thyroid Association Symposium on Radiation and the Thyroid. Lausanne, July 1987.

177. Samaan N.A., Vieto R., Schultz P.N. et al. Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 1982. Vol. 8. P. 1857.

178. Schimpff S.C., Diggs C.H., Wiswell J.G. et al. Radiation related thyroid dysfunction: implications for the treatment of Hodgkin's disease. Ann. Intern. Med. 1980. Vol. 92. P. 91.

179. Schneider A.B. Radiation-related thyroid cancer . The thyroid. A fundamental and clinical text. Eds. S.H.Ingbar, L.E.Braverman. 5th ed. Philadelphia, J.B.Lippincott, 1986, p. 801.

180. Schneider A.B., Favus M.J., Stachura M.E. et al. Plasma thyroglobulin in detecting thyroid carcinoma after childhood: head and neck irradiation. Ann. Intern. Med. 1977. Vol. 86. P. 29.

181. Schneider A.B., Score-Freedman E., Weinstein R.A. Radiation-induced thyroid and other head and neck tumors: occurrence of multiple tumors and analysis of risk factors. J. Clin. Endocrinol. Metab. 1986. Vol. 63. P. 107.

182. Shafer R.B., Nuttal F.Q., Pollak K., Kuisk H. Thyroid function after radiation and surgery for head and neck cancer. Arch. Intern. Med. 1975. Vol. 135. P. 843.

183. Shalet S.M. Thyroid dysfunction following external irradiation to the neck for Hodgkin's disease in childhood. Clin. Radiol. 1977. Vol. 28. P. 511.

184. Shigemitsu T., Sasao T. Effects of 131I treatment on the thyroid. Kaku Igaku. 1969. Vol. 6. P. 244.

185. Shiveli J.N., Epling G.P. Early changes in the fine structure of the midlethally irradiated thyroid dogs. Radiat. Res. 1969. Vol. 37. P. 71.

186. Shizume K. Long-term results of 131I treatment for hyperthyroidism. Naika. 1965. Vol. 16. P. 1277.

187. Shore R., Hempelmann L.H., Woodard E.D. Carcinogenic effects of radiation on the human thyroid gland. Radiation carcinogenesis. Eds. A.C.Upton, R.E.Albert, F.J.Furus, R.E.Shore. New York, 1986. P. 243.

188. Shore R.E., Woodward E.D., Hempelmann L.H. Radiation-induced thyroid cancer. Radiation carcino-genesis: epidemiology and biological significance. New York, 1984. P. 131.

189. Simon S.I., Lloyd R., Till J. et al. Development of a method to estimate thyroid dose from fallout radioiodine in a cohort study. Health Phys. 1990. Vol. 59. P. 669.

190. Slanina J. et al. Long-term side effects in irradiated patients with Hodgkin's disease. Cancer. 1981. Vol. 47. P. 2704.

200. Vagenakis A.G., Braverman L.E. Adverse effects of iodides on thyroid function. Med. Clin. N. Am. 1975. Int. J. Radiat. Oncol. Biol. Phys. 1977. Vol. 2. P. 1.

191. Smith R.E. Thyroid function after mantle irradiation in Hodgkin's disease. Cancer. 1981. Vol. 47. P. 2704.

200. Vagenakis A.G., Braverman L.E. Adverse effects of iodides on thyroid function. Med. Clin. N. Am. 1975. Cancer. 1981. Vol. 47. P. 2704.

200. Vagenakis A.G., Braverman L.E. Adverse effects of iodides on thyroid function. Med. Clin. N. Am. 1975. JAMA. 1981. Vol. 245. P. 46.

192. Spitalnik P.F., Straus F.H. Patterns of human thyroid parenchymal reaction following low-dose childhood radiation. Cancer. 1981. Vol. 47. P. 2704.

200. Vagenakis A.G., Braverman L.E. Adverse effects of iodides on thyroid function. Med. Clin. N. Am. 1975. Cancer. 1978. Vol. 41. P. 1098.

193. Stevens W., Till J.E., Thomas D.C. et al. Report of a cohort study of thyroid disease and radioactive fallout from the Nevada test site. National Cancer Institute, US Public Health Service Department of Health and Human Services, July 1992.

194. Stewart P.R., David C.L., Eftekhari F. et al. Thyroid gland: US in patients with Hodgkin's disease treated with radiation therapy in childhood. Radiology. 1989. Vol. 172. P. 159.

195. Sugiyama E., Shimokawa I., Iwasaki K. et al. Epidemiology of the thyroid cancer in Nagasaki-city with due regard for irradiation on atomic explo sion. Nagasaki Med. J. 1987. Vol. 62. P. 275.

196. Sugrue D., McEvoy M., Feely J., Drury M.I. Hyperthyroidism in the land of Graves': results of treatment by surgery, radioiodine and carbimazole in 837 cases. Q. J. Med. 1980. Vol. 49. P. 51.

197. Sundell-Bergmann S., Johansen K.J., Richter S. Enhancement of radiation sensivity in iododeoxyuridine labelled cells exposed to low energy X-rays. Acta Oncol. 1990. Vol. 29. P. 623.

198. Sutcliffe S.B., Chapman R., Wrigley P.F.M. Cyclical combination chemotherapy and thyroid function in patients with advanced Hodgkin's disease. Med. Ped. Oncol. 1981. Vol. 9. P. 439.

199. Tamura K., Shimaoka K., Friedman M. Thyroid abnormalities associated with treatment of malignant lymphoma. Cancer. 1981. Vol. 47. P. 2704.

200. Vagenakis A.G., Braverman L.E. Adverse effects of iodides on thyroid function. Med. Clin. N. Am. 1975. Vol. 59. P. 1075.

201. Van Best J.A. Comparison of thyroid function in mice after various injected activities of 123I, 125I and 131I. Int. J. Radiat. Biol. 1982. Vol. 42. P. 545.

202. Van Middlesworth L. Effect of radiation on the thyroid gland. Adv. Intern. Med. 1989. Vol. 34. P. 265.

203. Walinder G. Late effects of irradiation on the thyroid gland in mice. I. Irradiation of adult mice. Acta Radiol. Ther. Phys. Biol. 1972. Vol. 2. P. 433.

204. Wang Z., Boice J.D., Wei L. et al. Thyroid nodularity and chromosome aberrations among women in areas of high background radiation in China. J. Natl. Cancer Inst. 1990. Vol. 82. P. 478.

205. Wartofsky L., Burman K.D. Alterations in thyroid function in patients with systemic illness: The euthyroid sick syndrome. Endocrinol. Rev. 1982. Vol. 3. P. 164.

206. Watanabe I. Thyroid cancer following 131I therapy for hyperthyroidism. Geka Chiryo. 1980. Vol. 42. P. 385.

207. Wilson R., McKillop J.H., Black E. et al. Early prediction of hypothyroidism following 131I treatment for Graves' disease. Eur. J. Nucl. Med. 1988. Vol. 14. P. 180.

208. Wolf I. Risks to stable and radioactive iodine radiation of the thyroid. Thyroid disorders associated with iodine defiency and excess. New-York: Raven Press, 1985.

209. Yamashita H., Yasutake S. Results and late side effects of 131I treatment for hyperthyroidism. (in Japanese). Saishin Igaku. 1961. Vol. 16. P. 758.

210. Yoshii H. The statistic study of radioactive iodine therapy for hyperthyroidism. Nippon Igaku Hoshasen Gakkai Zasshi. 1981. Vol. 41. P. 33.

211. Zubovskiy G.A., Sarkisyan K.V., Matveenko E.G., Gorobets V.F. Radioisotope research methods in the diagnosis of diseases of the thyroid gland. Standardized methods of radioisotope diagnosis. Obninsk, 1987. C. 263-272.

212. Shishkin I.P., Matveenko E.G. State of the thyroid gland in patients with Hodgkin's disease after irradiation of the neck (long-term results). Radioisotope diagnosis of tumors: Abstracts of the report of the All-Union Conference. Leningrad, 1992. C. 90.

213. Chiacchierini R. Iodine-131 exposures and neoplasia. Radiat. Res. 1990. Vol. 124. P. 359-360.

214. Hamilton P., Chiacchierini R., Kaczmarek R. A follow-up of persons who had iodine-131 and other diagnostic procedures during childhood and adolescence. Publ. FDA 89-8276, CDRH Food and Drug Administration. Rockville, MD, 1989. P. 37.

215. Holm L., Wiklund K., Lundell G. Thyroid cancer after diagnostic doses of iodine-131: A retrospective cohort study. J. Natl. Cancer Inst. 1988. Vol. 80. P. 1132-1138.

216. Dedov I.I., Dedov V.I. Chernobyl: radioactive iodine thyroid gland. М., 1996. 236 с.

Full text article (in Russian)